Clinical Trial

AI-Assisted Detection of Posterior Segment Diseases: DR, AMD, RVO, and Glaucoma

Completed
View on ClinicalTrials.gov →
Summary
The purpose of this multi-center study is to evaluate the extent to which AI-assisted fundus image interpretation improves the diagnostic performance of ophthalmologists. Rather than assessing the standalone algorithm performance, this study aims to determine the clinical value of using AI as a decision-support tool within actual clinical workflows. At each participating institution, five ophthalmologists within three years of board certification and five ophthalmology residents will participate as readers. All readers will interpret fundus images both with and without the AI-based assistance software. The study will quantitatively compare diagnostic accuracy and reading time across the two conditions for four posterior segment diseases: diabetic retinopathy, age-related macular degeneration, retinal vein occlusion, and glaucoma.
Protocol Amendment History 1 change
critical Trial status changed: Enrolling by Invitation → Completed 2026-06-02
Trial Details
NCT Number NCT07318428
Lead Sponsor Inje University
Collaborators: Dong-A University Hospital, Kosin University Gospel Hospital, Pusan National University Hospital, Pusan National University Yangsan Hospital
Conditions Diabetic Retinopathy, Age Related Macular Degeneration, Retinal Vein Occlusion, Glaucoma, Glaucoma Suspect
Enrollment 10 participants
Start Date 2026-02-20
Primary Completion 2026-04-03 (estimated)
Study Completion 2026-05-22 (estimated)
Updated on ClinicalTrials.gov 2026-06-23